Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
$2.06B |
| 2 |
Nasdaq
NDAQ
|
$1.76B |
| 3 |
Wells Fargo
WFC
|
$1.1B |
| 4 |
Gilead Sciences
GILD
|
$978M |
| 5 |
Edwards Lifesciences
EW
|
$964M |
Top Sells
| 1 |
EOG Resources
EOG
|
$1.82B |
| 2 |
Apple
AAPL
|
$1.75B |
| 3 |
HCA Healthcare
HCA
|
$1.51B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$1.48B |
| 5 |
PNC Financial Services
PNC
|
$1.29B |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Healthcare | 19.6% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Nektar Therapeutics
NKTR
$764M
| $615K | ﹤0.01% |
+31,539
| New | +$615K |
|
1677
Weibo
WB
$2.87B
| $607K | ﹤0.01% |
60,195
+25,189
| +72% | +$254K |
|
1678
Cassava Sciences
SAVA
$104M
| $605K | ﹤0.01% |
+20,554
| New | +$605K |
|
1679
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $602K | ﹤0.01% |
7,500
-7,500
| -50% | -$602K |
|
1680
Franklin Resources
BEN
$13B
| $598K | ﹤0.01% |
29,667
+12,336
| +71% | +$249K |
|
1681
The Communication Services Select Sector SPDR Fund
XLC
$25.8B
| $589K | ﹤0.01% |
+6,512
| New | +$589K |
|
|
LENZ
1682
LENZ Therapeutics
LENZ
$1.2B
| $585K | ﹤0.01% |
+24,621
| New | +$585K |
|
1683
Evergy
EVRG
$16.5B
| $583K | ﹤0.01% |
9,397
-246,566
| -96% | -$15.3M |
|
1684
iShares MSCI Spain ETF
EWP
$1.36B
| $577K | ﹤0.01% |
+16,364
| New | +$577K |
|
1685
Permian Resources
PR
$9.75B
| $577K | ﹤0.01% |
42,404
+27,679
| +188% | +$377K |
|
1686
Tenaya Therapeutics
TNYA
$220M
| $568K | ﹤0.01% |
294,133
+77,235
| +36% | +$149K |
|
1687
ANI Pharmaceuticals
ANIP
$2.07B
| $561K | ﹤0.01% |
9,411
-34,218
| -78% | -$2.04M |
|
1688
Clorox
CLX
$15.5B
| $558K | ﹤0.01% |
3,428
-7,703
| -69% | -$1.25M |
|
1689
Innoviva
INVA
$1.29B
| $544K | ﹤0.01% |
28,166
-42,739
| -60% | -$825K |
|
1690
Yum! Brands
YUM
$40.1B
| $543K | ﹤0.01% |
3,885
-63,296
| -94% | -$8.84M |
|
1691
Akebia Therapeutics
AKBA
$785M
| $534K | ﹤0.01% |
+404,718
| New | +$534K |
|
1692
ADC Therapeutics
ADCT
$398M
| $531K | ﹤0.01% |
+168,557
| New | +$531K |
|
|
HUYA
1693
Huya Inc
HUYA
$796M
| $530K | ﹤0.01% |
103,852
+11,054
| +12% | +$56.4K |
|
1694
Arrow Electronics
ARW
$6.57B
| $522K | ﹤0.01% |
3,932
-230
| -6% | -$30.6K |
|
1695
FirstEnergy
FE
$25.1B
| $522K | ﹤0.01% |
11,764
-21,014
| -64% | -$932K |
|
|
CTLT
1696
DELISTED
CATALENT, INC.
CTLT
| $520K | ﹤0.01% |
8,585
-990
| -10% | -$60K |
|
1697
Royalty Pharma
RPRX
$15.6B
| $504K | ﹤0.01% |
17,806
-39,598
| -69% | -$1.12M |
|
1698
BioMarin Pharmaceuticals
BMRN
$11.1B
| $496K | ﹤0.01% |
7,059
+142
| +2% | +$9.98K |
|
1699
Arcutis Biotherapeutics
ARQT
$2.06B
| $494K | ﹤0.01% |
53,149
+923
| +2% | +$8.58K |
|
1700
Corbus Pharmaceuticals
CRBP
$121M
| $491K | ﹤0.01% |
+23,801
| New | +$491K |
|